Analysis of 49 astrocytoma samples showed that 16.3% (8/49) of cases had a methylated SFRP4 promoter while 83.7% (41/49) had an unmethylated one (Figure 4). The gene discussed is SFRP4; the disease is astrocytoma (excluding glioblastoma).